Hydroxyurea achieved a hematologic response in a patient with β‐thalassemia and secondary severe thrombocytosis post splenectomy

Pediatric Blood & CancerEarly View e31231 LETTER TO THE EDITOR Hydroxyurea achieved a hematologic response in a patient with β-thalassemia and secondary severe thrombocytosis post splenectomy Wenying Huang, Wenying Huang Department of Hematology, Zigong First People's Hospital, Zigong, ChinaSearch for more papers by this authorGuiping Liao, Guiping Liao Department of Hematology, The 923rd Hospital of the Joint Logistics Support Force of the People's Liberation Army, Nanning, ChinaSearch for more papers by this authorJian Xiao, Jian Xiao orcid.org/0009-0004-5291-1655 Department of Hematology, Zigong First People's Hospital, Zigong, ChinaSearch for more papers by this authorXiaodong Liu, Xiaodong Liu Department of Hematology, Zigong First People's Hospital, Zigong, ChinaSearch for more papers by this authorKun Yang, Corresponding Author Kun Yang [email protected] orcid.org/0000-0002-8619-9676 Department of Hematology, Zigong First People's Hospital, Zigong, China Department of Hematology, West China Hospital, Chengdu, China Correspondence Kun Yang, Department of Hematology, Zigong First People's Hospital, Zigong, 643000, China. Email: [email protected]Search for more papers by this author Wenying Huang, Wenying Huang Department of Hematology, Zigong First People's Hospital, Zigong, ChinaSearch for more papers by this authorGuiping Liao, Guiping Liao Department of Hematology, The 923rd Hospital of the Joint Logistics Support Force of the People's Liberation Army, Nanning, ChinaSearch for more papers by this authorJian Xiao, Jian Xiao orcid.org/0009-0004-5291-1655 Department of Hematology, Zigong First People's Hospital, Zigong, ChinaSearch for more papers by this authorXiaodong Liu, Xiaodong Liu Department of Hematology, Zigong First People's Hospital, Zigong, ChinaSearch for more papers by this authorKun Yang, Corresponding Author Kun Yang [email protected] orcid.org/0000-0002-8619-9676 Department of Hematology, Zigong First People's Hospital, Zigong, China Department of Hematology, West China Hospital, Chengdu, China Correspondence Kun Yang, Department of Hematology, Zigong First People's Hospital, Zigong, 643000, China. Email: [email protected]Search for more papers by this author First published: 25 July 2024 https://doi.org/10.1002/pbc.31231 Wenying Huang and Guiping Liao contributed equally to this work. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Taher AT, Musallam KM, Cappellini MD. β-Thalassemias. N Engl J Med. 2021; 384(8): 727-743. 10.1056/NEJMra2021838 PubMedWeb of Science®Google Scholar 2Akca T, Ozdemir GN, Aycicek A, Ozkaya G. Long-term results of splenectomy in transfusion-dependent thalassemia. J Pediatr Hematol Oncol. 2023; 45(3): 143-148. 10.1097/MPH.0000000000002468 CASPubMedGoogle Scholar 3Almanaseer A, Chin-Yee B, Ho J, et al. An approach to the investigation of thrombocytosis: differentiating between essential thrombocythemia and secondary thrombocytosis. Adv Hematol. 2024; 2024:3056216. 10.1155/2024/3056216 PubMedGoogle Scholar 4Thiele J, Kvasnicka HM, Orazi A, et al. The international consensus classification of myeloid neoplasms and acute leukemias: myeloproliferative neoplasms. Am J Hematol. 2023; 98(1): 166-179. 10.1002/ajh.26751 CASPubMedWeb of Science®Google Scholar 5Harrison CN, Bareford D, Butt N, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010; 149(3): 352-375. 10.1111/j.1365-2141.2010.08122.x CASPubMedWeb of Science®Google Scholar 6Khan PN, Nair RJ, Olivares J, Tingle LE, Li Z. Postsplenectomy reactive thrombocytosis. Proc (Bayl Univ Med Cent). 2009; 22(1): 9-12. 10.1080/08998280.2009.11928458 PubMedGoogle Scholar 7Sarbay H, Akbayram S. Secondary severe thrombocytosis in a patient who underwent splenectomy due to hereditary spherocytosis and its treatment using hydroxyurea. Pan Afr Med J. 2019; 32: 175. 10.11604/pamj.2019.32.175.17841 PubMedGoogle Scholar 8Barbui T. How to manage children and young adults with myeloproliferative neoplasms. Leukemia. 2012; 26(7): 1452-1457. 10.1038/leu.2012.12 CASPubMedWeb of Science®Google Scholar 9Dame C, Sutor AH. Primary and secondary thrombocytosis in childhood. Br J Haematol. 2005; 129(2): 165-177. 10.1111/j.1365-2141.2004.05329.x CASPubMedWeb of Science®Google Scholar 10Musallam KM, Taher AT, Cappellini MD, Sankaran VG. Clinical experience with fetal hemoglobin induction therapy in patients with beta-thalassemia. Blood. 2013; 121(12): 2199-2212. 10.1182/blood-2012-10-408021 CASPubMedWeb of Science®Google Scholar 11Banan M. Hydroxyurea treatment in beta-thalassemia patients: to respond or not to respond? Ann Hematol. 2013; 92(3): 289-299. 10.1007/s00277-012-1671-3 CASPubMedGoogle Scholar 12Ronchi A, Ottolenghi S. To respond or not to respond to hydroxyurea in thalassemia: a matter of stress adaptation? Haematologica. 2013; 98(5): 657-659. 10.3324/haematol.2013.084392 CASPubMedGoogle Scholar Early ViewOnline Version of Record before inclusion in an issuee31231 ReferencesRelatedInformation